Feature|Podcasts|March 24, 2025
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
Author(s)Miranda Schmalfuhs
Peter Ax, founder & CEO of UpScriptHealth, discusses the impact of tariffs on the pharmaceutical industry and how digital health platforms could potentially help offset them.
Advertisement
In this Pharmaceutical Executive podcast episode, UpScriptHealth founder and CEO Peter Ax discusses:
- The impact of tariffs on the pharmaceutical industry, highlighting branded and generics medications
- How tariffs could lead to strategic supply chain changes, including potential US manufacturing shifts
- How digital health platforms can help potentially offset tariff impacts
- The importance of telehealth in ensuring medication availability
- Strategic partnerships between digital health platforms and pharma companies to improve patient care and access
- and more
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
5